| 1 |
Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients |
|
| | Matilde Iorizzo, Michela Starace, Sergio Vano-Galvan, Bianca Maria Piraccini, Pascal Reygagne, Lidia Rudnicka, Tatiana Silyuk, Rodney Sinclair, Antonella Tosti | | | Journal of the American Academy of Dermatology. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Dermatoses inflammatoires et auto-immunes |
|
| | C. Lenormand, N. Kluger, C. Velter | | | Annales de Dermatologie et de Vénéréologie - FMC. 2022; 2(2): 2/2S3 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Refractory folliculitis decalvans treated with biologics: Case series in 4 situations |
|
| | Alejandro Lobato-Berezo, Ramon M. Pujol | | | Dermatologic Therapy. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Therapy-refractory folliculitis decalvans treated with certolizumab pegol |
|
| | Matthias Hoy, Markus Böhm | | | International Journal of Dermatology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life |
|
| | Donald E. Greydanus, Roua Azmeh, Maria Demma Cabral, Cheryl A. Dickson, Dilip R. Patel | | | Disease-a-Month. 2021; 67(4): 101103 | | | [Pubmed] [Google Scholar] [DOI] | |
|
